Clinical trials in Bethesda, MD

137 recruiting studies have a site in or near Bethesda, MD, Maryland.

Top conditions here

All conditions

Showing 40 of 137 studies

RecruitingPhase 1 / Phase 2NCT03109288

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Bethesda, MD

RecruitingPhase 1 / Phase 2NCT07667400

Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT02769975

Evaluation of Children With Endocrine and Metabolic-Related Conditions

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Bethesda, MD

RecruitingPhase not listedNCT05213572

Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Bethesda, MD

RecruitingPhase 1NCT06904066

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT06948110

Deciphering the Genetic Architecture of Autoimmune Diseases

Sponsor: National Human Genome Research Institute (NHGRI)

Bethesda, MD

RecruitingPhase 1NCT07169630

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

Sponsor: National Institute of Mental Health (NIMH)

Bethesda, MD

RecruitingPhase 2NCT07281456

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)

Bethesda, MD

RecruitingPhase 1NCT07509034

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT07619547

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Bethesda, MD

RecruitingPhase not listedNCT00001184

Immune Regulation in Ulcerative Colitis or Crohn s Disease

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Bethesda, MD

RecruitingPhase not listedNCT00001465

Study of the Disease Process of Lymphangioleiomyomatosis

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Bethesda, MD

RecruitingPhase not listedNCT00001532

Role of Genetic Factors in the Development of Lung Disease

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Bethesda, MD

RecruitingPhase not listedNCT00034216

Collection of Blood From Patients With Cancer

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT00060541

Evaluation and Treatment of Neurosurgical Disorders

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Bethesda, MD

RecruitingPhase not listedNCT00451022

Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT00542230

Blood Sampling for Research Related to Sickle Cell Disease

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Bethesda, MD

RecruitingPhase not listedNCT01087333

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 2NCT01174121

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT01834001

Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingNot applicableNCT02119611

Deep Brain Stimulation Therapy in Movement Disorders

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Bethesda, MD

RecruitingPhase not listedNCT02594202

Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 1NCT03065335

Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder

Sponsor: National Institute of Mental Health (NIMH)

Bethesda, MD

RecruitingPhase 2NCT03206060

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT03805919

Men at High Genetic Risk for Prostate Cancer

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 1NCT04222413

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Sponsor: National Cancer Institute (NCI)

Bethesda, MD · +1 more sites

RecruitingNot applicableNCT04692675

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT04706663

Precision-Based Genomics in Prostate Cancer

Sponsor: National Cancer Institute (NCI)

Bethesda, MD · +10 more sites

RecruitingPhase 1NCT04847063

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 1 / Phase 2NCT04959175

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

Sponsor: National Cancer Institute (NCI)

Bethesda, MD · +1 more sites

RecruitingPhase 2NCT05554393

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Bethesda, MD · +174 more sites

RecruitingPhase not listedNCT05588128

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT05588154

Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 1NCT06066138

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 2NCT06096870

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 2NCT06161506

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 1 / Phase 2NCT06364423

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 1NCT06885697

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT00242723

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT06732414

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Bethesda, MD

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.